批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2019/05/10 |
SUPPL-34(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/04/27 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/04/10 |
SUPPL-32(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/02/24 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/09/25 |
SUPPL-30(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/11/18 |
SUPPL-28(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2010/10/01 |
SUPPL-26(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/02/02 |
SUPPL-23(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2007/04/23 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/10/25 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/06/27 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/09/29 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/05/17 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/10/08 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/09/13 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2002/08/09 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/08/09 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/09/29 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/02/01 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2000/01/21 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/04/12 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1999/03/08 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/02/26 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1998/07/31 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1998/02/27 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1997/09/26 |
ORIG-1(原始申请) |
Approval |
Type 4 - New Combination |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:LAMIVUDINE; ZIDOVUDINE 剂型/给药途径:TABLET;ORAL 规格:150MG;300MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020857 |
001 |
NDA |
COMBIVIR |
LAMIVUDINE; ZIDOVUDINE |
TABLET;ORAL |
150MG;300MG |
Discontinued |
Yes |
No |
AB |
1997/09/26
|
VIIV HLTHCARE |
090246 |
001 |
ANDA |
LAMIVUDINE AND ZIDOVUDINE |
LAMIVUDINE; ZIDOVUDINE |
TABLET;ORAL |
150MG;300MG |
Prescription |
No |
No |
AB |
2012/05/15
|
LUPIN LTD |
202418 |
001 |
ANDA |
LAMIVUDINE AND ZIDOVUDINE |
LAMIVUDINE; ZIDOVUDINE |
TABLET;ORAL |
150MG;300MG |
Discontinued |
No |
No |
AB |
2012/05/15
|
AUROBINDO PHARMA LTD |
203259 |
001 |
ANDA |
LAMIVUDINE AND ZIDOVUDINE |
LAMIVUDINE; ZIDOVUDINE |
TABLET;ORAL |
150MG;300MG |
Prescription |
No |
No |
AB |
2014/02/03
|
HETERO LABS LTD V |
079128 |
001 |
ANDA |
LAMIVUDINE AND ZIDOVUDINE |
LAMIVUDINE; ZIDOVUDINE |
TABLET;ORAL |
150MG;300MG |
Prescription |
No |
No |
AB |
2015/05/13
|
STRIDES PHARMA |
079124 |
001 |
ANDA |
LAMIVUDINE AND ZIDOVUDINE |
LAMIVUDINE; ZIDOVUDINE |
TABLET;ORAL |
150MG;300MG |
Prescription |
No |
Yes |
AB |
2015/09/17
|
HETERO LABS LTD III |
077558 |
001 |
ANDA |
LAMIVUDINE AND ZIDOVUDINE |
LAMIVUDINE; ZIDOVUDINE |
TABLET;ORAL |
150MG;300MG |
Prescription |
No |
No |
AB |
2017/05/05
|
AUROBINDO PHARMA |
206375 |
001 |
ANDA |
LAMIVUDINE AND ZIDOVUDINE |
LAMIVUDINE; ZIDOVUDINE |
TABLET;ORAL |
150MG;300MG |
Prescription |
No |
No |
AB |
2018/04/10
|
EPIC PHARMA LLC |
090679 |
001 |
ANDA |
LAMIVUDINE AND ZIDOVUDINE |
LAMIVUDINE; ZIDOVUDINE |
TABLET;ORAL |
150MG;300MG |
Prescription |
No |
No |
AB |
2018/08/29
|
MACLEODS PHARMS LTD |
077411 |
001 |
ANDA |
LAMIVUDINE AND ZIDOVUDINE |
LAMIVUDINE; ZIDOVUDINE |
TABLET;ORAL |
150MG;300MG |
Prescription |
No |
No |
AB |
2018/09/07
|
CIPLA |